Typhoid can be economically catastrophic for families, despite accessible free medical care. Typhoid is costly for government healthcare provision. These data make an economic case for TCV introduction in Malawi and the region and will be used to derive vaccine cost-effectiveness.
No takes yet. Share an insight, caveat, or question.
Limani et al. (2022) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: